Want to join the conversation?
$REGN has a number of upcoming milestones for 2016 like Sarilumab (IL-6R Antibody), which has been filed for regulatory approvals outside of US; Dupilumab (IL-4R Antibody), which will report results from Phase 3 atopic dermatitis pivotal trials in 2016; & Fasinumab (NGF Antibody), which will report results from Phase 2b/3 study in osteoarthritis.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!